About • Abstracts • Lodging • Program • Registration • Sponsors • Venue

Sponsors

The 11th International Symposium on NeuroVirology and 2012 Conference on HIV in the Nervous System are being supported by generous contributions from numerous institutions and companies.

	The 2012 Conference is supported by a Public Health Service grant titled “Conference on HIV and the Nervous System” (1R13MH092200-01, Janice Clements, Ph.D., Principal Investigator). This grant is funded by the National Institute of Mental Health (NIMH) and National Institute of Neurological Disorders and Stroke (NINDS) at the National Institutes of Health (Bethesda, MD, USA).
	Financial support for the 11th International Symposium on NeuroVirology and the 2012 Conference on HIV in the Nervous System was generously provided by Pfizer, Inc. (www.pfizer.com) through a medical education grant.
	Travel awards for investigators presenting research related to the intersection of substance use and HIV in the CNS were provided by the AIDS Research Program, National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (Bethesda, MD, USA). The role of the NIDA AIDS Research Program (www.drugabuse.gov/AIDS) is to support the development, planning, and coordination of HIV/AIDS priority research within NIDA's intramural and extramural programs, in order to ensure an integrated vision and strategy to guide HIV/AIDS research throughout NIDA. The overall mission of NIDA is to lead the nation in bringing the power of science to bear on drug abuse and addiction.
	The Journal of NeuroVirology (www.jneurovirol.com) is the official journal of the ISNV. This bi-monthly journal provides a unique platform for the publication of high-quality basic science and clinical studies on the molecular biology and pathogenesis of viral infections of the nervous system, and for reporting on the development of novel therapeutic strategies using neurotropic viral vectors. The Journal also emphasizes publication of non-viral infections that affect the central nervous system. The Journal publishes original research articles, reviews, case reports, coverage of various scientific meetings, along with supplements and special issues on selected subjects.
	The Department of Microbiology and Immunology (www.drexelmed.edu/microimmuno) in the Drexel University College of Medicine (Philadelphia, PA, USA) is involved on an annual basis in the education of more than 265 medical students, 60 graduate students, and more than 20 post-graduate scientists in training. Utilizing basic, translational, and clinical research strategies and cutting edge technologies, the faculty (totaling more than 90) are actively engaged in research and education in the areas of virology, malarial, bacterial, and fungal pathogenesis; emerging infectious disease and biodefense; opportunistic infections; drug discovery and development; immunology and vaccine science; molecular and human genetics; biomarkers and diagnostics; neuro-infectious disease; and cancer biology.
	The Institute for Molecular Medicine and Infectious Disease (www.drexelmed.edu/immid) in the Drexel University College of Medicine (Philadelphia, PA, USA) is a collaborative inter-campus enterprise focused on research, diagnosis, treatment, prevention, and clinical management of infectious, inflammatory, oncogenic, metabolic and genetic disorders. The Institute facilitates the development and expansion of 14 Research Centers of Excellence (RCEs) and the training and development of graduate students, postdoctoral fellows, residents, and junior faculty within an organized framework to guide the development of inter-campus, inter-college, and inter-unit research initiatives across the University as well as with other academic, industrial, and governmental organizations at the regional, national, and international levels.
	The Office of the Vice Dean for Research in the Drexel University College of Medicine (Philadelphia, PA, USA) serves to support clinical and basic research activities, works with departments and interdisciplinary programs to develop and implement research, facilitates translational research, and promotes mentoring to advance the training of physicians and scientists.
	The Department of Neuroscience in the Temple University School of Medicine (Philadelphia, PA, USA) is a state-of-the-art multidisciplinary research and education entity. Our mission is to foster a collaborative environment that enables superior research leading to an understanding of the mechanisms of disorders of the central nervous system. This leads to novel therapeutic strategies directed against relevant diseases. The variety and intensity of approaches provide an integrative graduate and postgraduate program that trains first-rate scientists in the field of neuroscience who will successfully contribute new and innovative ideas and technologies well into the future.
	Financial support was provided in part by the Laboratory of Molecular Medicine and Neuroscience (LMMN) for the Investigators in Training Award. The LMMN is in the Division of Intramural Research, in the National Institute of Neurological Disorders and Stroke (NINDS) at the National Institutes of Health (Bethesda, MD, USA). The mission of the NINDS (www.ninds.nih.gov) is to reduce the burden of neurological disease - a burden borne by every age group, by every segment of society, and by people all over the world.
	Located in Camden, NJ, USA, the Cooper Medical School of Rowan University (www.rowan.edu/CooperMed) is committed to providing humanistic education in the art and science of medicine within a scientific and scholarly community in which inclusivity, excellence in patient-care, innovative teaching, research, and service to our community are valued. In June 2009, Rowan University and Cooper Health System partnered to create what was to become the first new medical school in New Jersey in more than 30 years. It will enroll its first class in fall 2012.
	Gilead Sciences (www.gilead.com) is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need. Gilead’s mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe, and Asia Pacific.
	The Symposium and Conference were generously supported by an educational grant from Janssen Pharmaceuticals, Inc. (www.janssenpharmaceuticalsinc.com), administered by Janssen Scientific Affairs, LLC. Headquartered in Titusville, New Jersey, Janssen Pharmaceuticals provides medicines for an array of health concerns in several therapeutic areas, including: attention deficit hyperactivity disorder (ADHD), general medicine (acid reflux disease, infectious diseases), mental health (bipolar I disorder, schizophrenia), neurologics (Alzheimer’s disease, epilepsy, migraine prevention and treatment), pain management, and women’s health.
	Since 1968, the Temple University College of Engineering (www.temple.edu/engineering/) has been providing students with a first-rate engineering education. Within its four departments, the college offers six undergraduate and six graduate programs, including a doctoral degree. Graduate-level instruction and research are guided by a talented faculty who are on the cutting-edge of research in critical areas including targeted drug delivery, regenerative medicine, environmental biotechnology, scour countermeasures for bridges, tactile imaging sensors and solar cell materials. The College of Engineering offers its students numerous opportunities for academic, professional and personal development through several student professional organizations, an optional undergraduate co-op program, research experiences, and many seminars and guest lectures. Furthermore, the college is located on Temple University’s main campus, in Philadelphia, Pennsylvania – a thriving city at the forefront of science and technology.
	Biogen Idec (www.biogenidec.com) is among the world's leading global biotechnology companies. They are a Fortune 500 company with over $4 billion in revenue. Patients in more than 90 countries benefit from their products, which include Tysabri and Avonex for the treatment of multiple sclerosis, and Rituxan for non-Hodgkins lymphoma.
	Financial support for the Symposium and Conference was generously provided by Dr. John Jenkins (United Kingdom).
	The T. and L. de Beaumont Bonelli Foundation for Cancer Research was officially recognized by Italian Presidential Decree No. 36 on January 3, 1978. The aim of the Foundation is to promote scientific research pertaining to cancer. The Foundation was instituted thanks to the generous donation of the late Teresa Berger, who left a large part of her fortune to the Foundation, whereas her late husband, EarI Luigi de Beaumont Bonelli, left most of his fortune to the Nobel Foundation.
	The mission of the National Multiple Sclerosis Society (www.nmss.org) is to mobilize people and resources to drive research for a cure and to address the challenges of everyone affected by multiple sclerosis (MS).
	The Sbarro Health Research Organization, Inc. (www.shro.org/SHRO/) is a nonprofit charity committed to funding excellence in basic genetic research to cure and diagnose cancer, cardiovascular diseases, diabetes, and other chronic illnesses, and to foster the training of young doctors in a spirit of professionalism and humanism. The Organization is based in Philadelphia, Pennsylvania, on the campus of Temple University.